Read
- IRS official refuses to answer questions at scandal hearing
|
- Global stocks, oil fall after Bernanke; dollar gains
|
- Oklahoma tornado victims astounded at how they survived
|
- CORRECTED-White House threatens veto of bill to bypass Obama on Keystone
- FBI says man shot dead while being questioned about Boston bombings
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Message of humility
A religious fraternity in Rio considers the election of Pope Francis, a confirmation of their beliefs in poverty and simplicity. Slideshow
Sponsored Links
Google investor sues board over online drug ads
SAN FRANCISCO |
SAN FRANCISCO (Reuters) - Google Inc's board of directors faces a lawsuit for previously allowing Canadian pharmacies to advertise prescription drugs to U.S. customers via the Web search leader.
The civil lawsuit, filed on behalf of a Google shareholder on Monday, claims the ads -- which Google stopped displaying in February 2010 -- led to what it calls the "illegal importation" of the drugs.
The lawsuit follows Google's $500 million settlement last week of a U.S. criminal probe over such ads. The shareholder charges that the board breached its fiduciary duty and seeks unspecified damages.
Last week the Department of Justice said Google agreed to settle the investigation into ads it accepted for online Canadian pharmacies selling drugs in the United States.
The advertisements led to illegal imports of prescription drugs into the country, the regulator said.
Google representatives did not immediately respond to a request for comment.
The case in U.S. District Court, Northern District of California is Patricia M. McKenna, derivatively on behalf of Google Inc., v. Larry Page, Sergey Brin, Eric Schmidt et al., No. 11-4248.
For McKenna: Shawn Williams, Darren Robbins, Travis Downs, Benny Goodman and Erik Luedeke of Robbins Geller Rudman & Dowd.
For Google's board: Not immediately available.
(Reporting by Dan Levine)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints



Follow Reuters